Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2026-02-09 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
关于公司银行贷款展期暨继续提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's bank loan extension and continued provision of guarantees. It details the loan amount, collateral assets, meeting resolutions, and the purpose and impact of the loan extension. There are no financial statements, quarterly or annual results, or audit information presented. The document is relatively short (1355 characters) and serves as a formal disclosure of financing activity related to bank loans and collateral. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2026-02-09 Chinese
关于关联借款展期暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the extension of a related party loan (关联借款展期) between the company and its controlling shareholder, detailing the terms of the loan extension, the related party relationship, and approvals by the board and independent directors. It does not contain financial statements or comprehensive financial data but rather focuses on a specific financing transaction and related governance approvals. The document length is 3305 characters, which is relatively short and consistent with an announcement rather than a full report. This fits the category of Capital/Financing Update (CAP), as it updates on company financing activities and capital structure changes involving related party loans.
2026-02-09 Chinese
关于召开2026年第二次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2026 second extraordinary general meeting of shareholders for a company, detailing the meeting time, location, agenda, voting procedures, and registration information. It includes information about proposals to be voted on and instructions for shareholders to participate in the meeting and vote, including proxy voting. There are no financial statements, earnings data, or detailed management analysis. The document is an announcement of a shareholders meeting, not the meeting materials or voting results themselves. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2026-02-09 Chinese
关于注销孙公司的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company about the deregistration (cancellation) of a subsidiary. It includes details about the subsidiary, the deregistration process, and the impact on the parent company. There are no financial statements, no mention of annual or quarterly reports, no audit information, no voting results, no management changes, no earnings data, and no legal proceedings. The document is a formal regulatory announcement about a corporate structural change (subsidiary cancellation). It is not a report itself but an announcement of a corporate event. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-05 Chinese
关于股票可能被终止上市的第一次风险提示暨年度报告编制及审计进展公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from a listed company regarding the risk of its stock being delisted due to financial distress, including negative net assets and consecutive years of losses. It references specific stock exchange listing rules and details the progress of the annual report audit for the upcoming fiscal year. The document is relatively short (3704 characters) and primarily serves as a risk warning and update on the audit progress rather than containing the full annual report or detailed financial statements. It repeatedly mentions that the annual report is still being prepared and audited, and that further risk warnings will be issued periodically until the report is published. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about risks and audit progress, not the actual annual report (10-K) or audit report (AR).
2026-01-27 Chinese
2025年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2025 annual performance forecast (业绩预告) for the company *ST 绿康, covering the period from January 1, 2025 to December 31, 2025. It provides preliminary estimated financial results including net profit, total profit, earnings per share, and revenue, with explanations about the reasons for performance changes and risk warnings. The document explicitly states that the final audited financial data will be disclosed in the 2025 annual report. The document length is 2286 characters, which is relatively short and mainly serves as a forecast or preliminary announcement rather than a full financial report. It does not contain full audited financial statements or detailed financial analysis. Therefore, it is not an Annual Report (10-K) or Interim Report (IR). It is also not a simple announcement of report publication (RPA) because it contains substantive forecast data and explanations. The document fits best as an Earnings Release (ER) because it announces key highlights of expected financial results for the fiscal year before the full annual report is available. Hence, the classification is Earnings Release (ER) with high confidence. FY 2025
2026-01-27 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.